Calnexin anticorps (C-Term) (Atto 488)
Aperçu rapide pour Calnexin anticorps (C-Term) (Atto 488) (ABIN1965601)
Antigène
Voir toutes Calnexin (CANX) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- Detects ~90kD.
-
Purification
- Protein A purified
-
Immunogène
-
Dog Calnexin C-terminal synthetic peptide conjugated to KLH. Identical to human, mouse and rat calnexin sequences over these residues.
Type of Immunogen: Synthetic peptide - KLH conjugated
-
-
-
-
Indications d'application
-
Approved: Flo, ICC, IHC, IP, WB
Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.2, 0.09 % sodium azide, 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C.
-
-
- Calnexin (CANX)
-
Autre désignation
- CANX / Calnexin
-
Sujet
-
Name/Gene ID: CANX
Synonyms: CANX, CNX, Calnexin, IP90, p90 -
ID gène
- 821
-
Pathways
- Signalisation MAPK, Thyroid Hormone Synthesis
Antigène
-